Autologous Stem Cell Transplantation (ASCT)

PROCEDURE4 trials

Conditions

Contiguous Stage II Mantle Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Light Chain (AL) AmyloidosisLymphomaNoncontiguous Stage II Mantle Cell LymphomaStage I Mantle Cell LymphomaStage III Mantle Cell LymphomaStage IV Mantle Cell Lymphoma

Phase 1

A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients

Active, not recruitingNCT03352765

Memorial Sloan Kettering Cancer CenterLymphoma

Start: 2017-11-20End: 2026-11-30Target: 28Updated: 2025-12-04

Phase 2

Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma

CompletedNCT00433537

National Cancer Institute (NCI)Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma +2

Start: 2007-05-31End: 2013-06-30Updated: 2014-10-30

A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Not yet recruitingNCT07599423

The First Affiliated Hospital of Soochow UniversityDiffuse Large B Cell Lymphoma (DLBCL)

Start: 2026-07-22End: 2030-12-31Target: 96Updated: 2026-07-13

Unknown Phase

Daratumumab for Patients With Light Chain Amyloidosis

RecruitingNCT06376214

Nanjing University School of MedicineLight Chain (AL) Amyloidosis

Start: 2023-01-01End: 2026-12-31Target: 100Updated: 2024-04-19

Related Papers

Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405).